G1 Therapeutics Inc Revenue per Employee (GTHX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
G1 Therapeutics Inc   (NASDAQ: GTHX)
 

G1 Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


G1 Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,058,091, but the productivity of G1 Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 61 other companies have achieved higher revenue per employee. While G1 Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 563. G1 Therapeutics Inc has 55 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GTHX Revenue per Employee (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Revenue Change -60.97 % 11.82 % 45.1 % -47.83 % 300.95 %
Sales per Employee (TTM) $ 1,058,091 1,528,018 1,500,200 1,416,145 1,621,164
GTHX's Total Ranking # 563 # 0 # 0 # 0 # 0
Seq. Revenue Change 14.3 % -2.67 % 20.92 % -70.99 % 227.45 %

GTHX Company Profile >> Back to GTHX Efficiency Comparisons >> Compare GTHX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 62
Overall Market # 563

Revenue per Employee Statistics
High Average Low
$ 1,897,106 $ 1,210,871 $ 514,043
(Jun 30 2023)   (Mar 31 2022)



Financial Statements
G1 Therapeutics Inc 's Revenue MRQ $ 17 Millions Visit GTHX's Income Statement
G1 Therapeutics Inc 's Revenues TTM $ 58 Millions Visit GTHX's aggregate revenue growth
What are GTHX's Sales? Visit GTHX's Sales by Segment




Other Ratios
G1 Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GTHX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GTHX's Competitors
Revenue per Employee for GTHX's Suppliers
Revenue per Employee for GTHX's Customers

You may also want to know
GTHX's Sales Growth Rates GTHX's Pe Price to earnings ratio GTHX's Receivables Turnover Ratio GTHX's Stock Quote
GTHX's Net Income Growth Rates GTHX's Ps Price to Sales ratio GTHX's Sales per Employee GTHX's Asset Turnover Ratio
GTHX's Net Margin GTHX's Pb Price to Book ratio GTHX's Financial Strength Ratios GTHX's Dividend Payout Ratio
Date modified: 2026-08-30T19:08:52+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2024Number of Employees Jun 30 2024
Sarepta Therapeutics Inc   1,802,386.83 $ 1,504.993  Million 835 
Exelixis Inc   1,755,863.99 $ 2,013.976  Million 1,147 
Cytomx Therapeutics Inc   1,732,884.06 $ 119.569  Million 69 
Gilead Sciences Inc   1,635,588.24 $ 27,805.000  Million 17,000 
Paragon 28 inc   1,620,729.17 $ 233.385  Million 144 
Aurinia Pharmaceuticals Inc   1,618,007.81 $ 207.105  Million 128 
Entrada Therapeutics Inc   1,574,980.26 $ 239.397  Million 152 
Ispecimen inc   1,500,931.29 $ 10.507  Million 7 
Scilex Holding Company  1,495,088.24 $ 50.833  Million 34 
Nektar Therapeutics  1,478,682.54 $ 93.157  Million 63 
Arcturus Therapeutics Holdings Inc   1,476,270.27 $ 163.866  Million 111 
Keenova Therapeutics Plc  1,431,875.00 $ 2,291.000  Million 1,600 
Bristol myers Squibb Company  1,431,046.15 $ 46,509.000  Million 32,500 
Telesis Bio Inc   1,420,090.91 $ 15.621  Million 11 
Fennec Pharmaceuticals Inc   1,396,828.57 $ 48.889  Million 35 
Privia Health Group Inc   1,383,098.69 $ 1,695.679  Million 1,226 
Petros Pharmaceuticals inc   1,373,552.33 $ 4.121  Million 3 
Collegium Pharmaceutical Inc   1,360,089.83 $ 575.318  Million 423 
Incyte Corporation  1,356,193.39 $ 3,857.014  Million 2,844 
Jazz Pharmaceuticals Plc  1,352,900.69 $ 3,909.883  Million 2,890 
Journey Medical Corp  1,339,327.59 $ 77.681  Million 58 
Progyny Inc   1,321,788.55 $ 1,131.451  Million 856 
Novavax inc   1,318,647.53 $ 987.667  Million 749 
Biogen Inc   1,289,600.00 $ 9,672.000  Million 7,500 
Precision Biosciences Inc  1,288,823.53 $ 87.640  Million 68 
Xenetic Biosciences Inc   1,260,197.50 $ 2.520  Million 2 
Axonics Inc   1,253,556.92 $ 407.406  Million 325 
Sutro Biopharma Inc   1,236,197.08 $ 169.359  Million 137 
Puma Biotechnology Inc   1,224,262.57 $ 219.143  Million 179 
Emergent Biosolutions Inc   1,223,777.78 $ 1,101.400  Million 900 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.